Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sanara MedTech ( (SMTI) ) just unveiled an update.
On August 29, 2025, Sanara MedTech‘s Board of Directors appointed Seth D. Yon as the new President and Chief Executive Officer, effective September 15, 2025, succeeding Ronald T. Nixon, who will continue as Executive Chairman. This leadership transition is part of a strategic initiative to position Sanara for future growth, with Mr. Yon bringing extensive experience from his previous roles within the company, contributing to its significant revenue growth. Additionally, Ashley Mackey was designated as the principal accounting officer, succeeding Elizabeth B. Taylor, who remains the Chief Financial Officer.
The most recent analyst rating on (SMTI) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Sanara MedTech stock, see the SMTI Stock Forecast page.
Spark’s Take on SMTI Stock
According to Spark, TipRanks’ AI Analyst, SMTI is a Neutral.
Sanara MedTech’s overall stock score is driven by strong technical indicators, suggesting bullish momentum, and robust revenue growth in the Surgical segment. However, significant profitability and cash flow challenges, along with a negative P/E ratio, weigh down the score. The company’s reliance on debt financing and the ongoing losses in the THP segment add further risk.
To see Spark’s full report on SMTI stock, click here.
More about Sanara MedTech
Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies aimed at improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound, and skin markets. The company markets and distributes a range of surgical, wound, and skin products primarily in the North American advanced wound care and surgical tissue repair markets.
Average Trading Volume: 45,852
Technical Sentiment Signal: Strong Buy
Current Market Cap: $299.7M
For a thorough assessment of SMTI stock, go to TipRanks’ Stock Analysis page.